InMed Pharmaceuticals (INM) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
InMed Pharmaceuticals announced the results of their 2024 Annual General Meeting, where shareholders approved the election of four directors and the appointment of CBIZ LLP as their auditors for the coming year. However, the election of Ms. Janet Grove was withheld, prompting her resignation offer, which is under consideration. The company is focused on developing drug candidates for diseases with high unmet needs.
For further insights into INM stock, check out TipRanks’ Stock Analysis page.
